- Home
- SWTX vs SGRY Comparison
SWTX vs SGRY Comparison
Compare SWTX & SGRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWTX
- SGRY
- Stock Information
- Founded
- SWTX 2017
- SGRY 2004
- Country
- SWTX United States
- SGRY United States
- Employees
- SWTX N/A
- SGRY N/A
- Industry
- SWTX Biotechnology: Pharmaceutical Preparations
- SGRY Hospital/Nursing Management
- Sector
- SWTX Health Care
- SGRY Health Care
- Exchange
- SWTX Nasdaq
- SGRY Nasdaq
- Market Cap
- SWTX 3.0B
- SGRY 2.7B
- IPO Year
- SWTX 2019
- SGRY 2015
- Fundamental
- Price
- SWTX $58.25
- SGRY $25.31
- Analyst Decision
- SWTX Strong Buy
- SGRY Buy
- Analyst Count
- SWTX 6
- SGRY 9
- Target Price
- SWTX $70.83
- SGRY $37.38
- AVG Volume (30 Days)
- SWTX 3.2M
- SGRY 1.7M
- Earning Date
- SWTX 02-20-2025
- SGRY 03-03-2025
- Dividend Yield
- SWTX N/A
- SGRY N/A
- EPS Growth
- SWTX N/A
- SGRY N/A
- EPS
- SWTX N/A
- SGRY N/A
- Revenue
- SWTX $191,589,000.00
- SGRY $2,985,300,000.00
- Revenue This Year
- SWTX $3,475.18
- SGRY $14.46
- Revenue Next Year
- SWTX $81.60
- SGRY $9.94
- P/E Ratio
- SWTX N/A
- SGRY N/A
- Revenue Growth
- SWTX 3417.33
- SGRY 9.96
- 52 Week Low
- SWTX $28.21
- SGRY $19.50
- 52 Week High
- SWTX $62.00
- SGRY $34.11
- Technical
- Relative Strength Index (RSI)
- SWTX 70.71
- SGRY 59.37
- Support Level
- SWTX $54.89
- SGRY $25.20
- Resistance Level
- SWTX $62.00
- SGRY $26.16
- Average True Range (ATR)
- SWTX 4.09
- SGRY 0.48
- MACD
- SWTX 1.35
- SGRY -0.10
- Stochastic Oscillator
- SWTX 85.90
- SGRY 11.46
About SWTX SpringWorks Therapeutics Inc.
SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.
About SGRY Surgery Partners Inc.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It operates in two segments: Surgical Facility Services and Ancillary Services out of which the Surgical Facility Services segment accounts for the majority of revenue.